Loading Events

Dr. Hillary Rouse, Life Molecular Imaging, Medical Science Liaison
Dr. Rouse is a Medical Science Liaison at Life Molecular Imaging. She completed her PhD in Aging Sciences, MS in Aging & Neuroscience, and MA in Gerontology. She has over 15 years of experience within the Alzheimer’s field; working with people with the disease, conducting research, and administering neuropsychological assessments. She has contributed to over a dozen publications, numerous presentations, and received several research awards. She is a member of the Alzheimer’s Association International Society to Advance Alzheimer’s Research and Treatment (ISTAART), Society for Nuclear Medicine & Molecular Imaging (SNMMI), Gerontological Society of America (GSA), and more.

Date: September 28, 2023
Time: 3:30pm – 4:30pm EDT

Who should attend? PET Interpreters, Technologists, Referring Physicians, Marketers

In this session, Dr. Rouse will help you to:

  • gain an understanding of dementia subtypes and the difference between a diagnosis of mild cognitive impairment (MCI) and Alzheimer’s disease (AD) dementia
  • learn about available Alzheimer’s disease biomarkers and their role in early diagnosis and monitoring of disease progression and response to treatment
  • discover how diagnostic biomarker modalities differ (i.e., MRI vs PET scan) and the importance of brain imaging for diagnostic purposes
  • learn how PET imaging, alongside other clinical evaluations, can aid differential diagnosis and the impact of an accurate diagnosis on patients and their clinical care management


Share This Story, Choose Your Platform!

Go to Top